Department of Chemistry, Zhejiang University, Hangzhou 310027, P. R. China.
ACS Appl Mater Interfaces. 2020 Nov 4;12(44):49431-49441. doi: 10.1021/acsami.0c15494. Epub 2020 Oct 22.
Oral administration of medicine faces physiological constraints imposed by the gastrointestinal tract (GIT) and simultaneously causes irritation to GI mucosa, which motivates us to pursue the innovation of a GI drug delivery system. Inspired by the mucosa-nutrient functions of Zinc element and smectite clay, a montmorillonite (MMT)-enveloped zeolitic imidazolate framework (M-ZIF-8) is developed in a successive one-pot fabrication of ZIF-8 encapsulated medicine, and followed MMT coating to yield a core-shell nanoplatform for GI drug delivery. ZIF-8 encapsulated medicines can maintain their intrinsic structure, and MMT layer potentiates mucous-adhesion and optimizes medicine release. Validated in gastritis and colitis models, M-ZIF-8 not only achieves efficient GI delivery of nonsteroidal anti-inflammatory drugs (NSAIDs) for inflammation inhibition, but also reduces the NSAIDs-induced GI irritation, promoting mucosal healing in GIT. Coupled with the facile construction and biocompatibility, M-ZIF-8 shows a significant advancement in GI drug delivery.
口服给药面临胃肠道(GIT)带来的生理限制,同时会刺激 GI 黏膜,这促使我们寻求胃肠道药物递送系统的创新。受锌元素和蒙脱石粘土的黏膜-营养功能的启发,采用连续一锅法制备了沸石咪唑酯骨架-8(ZIF-8)包裹药物,并进一步进行蒙脱石(MMT)涂层,得到用于胃肠道药物递送的核壳纳米平台。ZIF-8 包裹的药物可以保持其固有结构,而 MMT 层增强了黏膜黏附性并优化了药物释放。在胃炎和结肠炎模型中得到验证,M-ZIF-8 不仅实现了非甾体抗炎药(NSAIDs)的高效胃肠道递送以抑制炎症,还减轻了 NSAIDs 引起的胃肠道刺激,促进了 GIT 黏膜愈合。结合简便的构建和生物相容性,M-ZIF-8 在胃肠道药物递送方面取得了显著进展。